Reactive protein, plasminogen activator inhibitor type-1 (PAI-1) levels, PAI-1 promoter 4G/5G polymorphism and acute myocardial infarction

Journal of Geriatric Cardiology

Volumn 7, Issue 3-4, 2010, Pages 147-151

  Cao, Xue Lei ^a   Zhou, Chang Yong ^a   Yin, Lei ^a   Wang, Shao Chun ^a   Jia, Xiu Ling ^a   Huang, Huan ^a   Sun, Xiao Hong ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

C reactive protein; Non ST segment elevation myocardial infarction; Plasminogen activator inhibitor 1; ST segment elevation myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 79956271002     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ziakas A, Gavrilidis S, Giannoglou G, et al. In-hospital and long -term Prognostic value of fibrinogen, CR P, and IL-6 levels in patients with acute myocardial infarction [J]. Angiology.2006; 57(3); 283-93.
2. Lindahl B, Toss H, Slegbahn A, et al Markers of myocardial damage andinflammation in relation to long-termmortality in unstable coronary arterydisease:FRISC study group, Fragmin during instability in coronary artery disease[J]. N Eng J Med, 2000.343(16);1139-47.
3. Dawson S, Hamsten A, Wiman B, et al. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb. 1991;11:183-90.
4. Boeckoldt SM, Bijsterveld NR, Moon AH, et al. Genetic variation in coagulation and fibrinolytic protein and their relation with acute myocardial infarction: a systematic review. Circulation. 2001;104:3064-8.
5. Weinberg W. On Demonstration of Heredity in Man: Papers of Human Genetics. Englewood Cliffs, NJ: Prentice Hall; 1963.
6. Tomoda H, Aoki N. Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction. Am Heart J 2000; 140: 324-8. (Pubitemid 30641598)
7. David Rott, David Leibowitz The Relationshi p of Plasminogen Activator Inhibitor-1 Levels to the ST Deviation Pattern of Acute Myocardial Infarction Cardiology 2009;
8. Sinkovic A, Pogacar V. Risk stratification in patients with unstable angina and /or non-ST-elevation myocardial infarction by troponin T and Plasminogen activator inhibitor-1 (PAI-1) [J]. Thromb Haemost, 2004, 91 (5): 1026-30.
9. von Eyben FE, Mouritsen E, Holm J , et al. Plasminogen activator inhibitor 1 activity and other coronary risk factors[J]. Clin APP l Thromb Hemost, 2005, 11 (1): 55-61. (Pubitemid 40194198)
10. Changyi Chen, Bicheng Nan, Peter Lin, et al, C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells, Thrombosis Research, 2008;122: 125-33.
11. Nakakuki T, Ito M, Iwasaki H, et al. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 in endothelial cells. Arterioscler Thromb Vasc Biol 2005;25:2088-93. (Pubitemid 41416305)
12. Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000: 148: 209-14.
13. Hoekstra T, Geleijnse JM, Schouten EG, et al. Plasminogen activator inhibitortype 1: its plasma determinants and relation with cardiovascular risk. Thromb Haemost 2004; 91:861-72. (Pubitemid 38647488)
14. Pradhan AD, Ridker PM. Do atheroscierosis and 2 diabetes share a common inflammatory basis? [J]. Eur Heart J,2002,23(11):831-4.
15. R. Testa, A.R. Bonfigli , C. Sirolla, et al, C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position L675 of the PAI-1 gene, Nutrition, Metabolism & Cardiovascular Diseases 2008, 18, 220-6. (Pubitemid 351374795)
16. Menges T, Hermans PW, Little SG ,et al. Plasminogen activator inhibitor-1 4G/ 5G promoter polymorphism and Prognosis of severely injured patients.Lancet, 2001, 357: 1096-97.
17. Irma Isordia-Salas Association of the Plasminogen Activator Inhibitor-1 Gene 4G/5G Polymorphism with ST Elevation Acute Myocardial Infarction in Young Patients.Esp Cardiol. 2009; 62(04): 365-72.
18. Boncoraglio GB, Bodini A, Brambila C, et al. An Effect of the PAI-1 4G/4G polymorphism on cholesterol levels may explain conflicting association with myocardial infarction and stoke. Cerebrovasc Dis. 2006; 22:191-5. (Pubitemid 44114463)
19. Nilsson JB, Boman K, Jansson JH, et al. The influence of acute- phase levels of haemostatic factors on re perfusion and mortality in patients with acute myocardial infarction treated with stre ptokinase. J Thromb Thrombolysis. 2008; 26: 188-95.
20. Ericksson P, Kallin B, van't Hooft FM, et al. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction[J]. Proc Natl Acad Sci USA, 1995, 92: 1851-5.
21. Mikkelsson J, Pemla M, Wariovaara U, et al. Plasminogen activator inhibitor- 1 ( PAI-1)4C/5G polymor phism, coronary thrombosis and myocardial infarction in middle-aged Finish men who died suddenly. Thromb Haemost, 2000; 84:78-82. (Pubitemid 30433672)